Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ames

Showing results (341-350 of 416) with videos related to

Pageof 42
Sort By:
Neuro-Oncology|August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I studyKristin A Bradley, Ian F Pollack, Joel M Reid, et al.
BMC Research Notes|April 24, 2014
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I studyMin H Kang, Judith G Villablanca, Julia L Glade Bender, et al.
Science Advances|January 31, 2020
Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancerJimena G Dancy, Aniket S Wadajkar, Nina P Connolly, et al.
Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.
American Journal of Respiratory and Critical Care Medicine|September 5, 2009
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary diseaseChristine M Freeman, Fernando J Martinez, MeiLan K Han, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Nature|July 21, 2022
ADAR1 mutation causes ZBP1-dependent immunopathologyNicholas W Hubbard, Joshua M Ames, Megan Maurano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumorsMatthew P Goetz, Charles Erlichman, Anthony J Windebank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatinI I Budihardjo, D L Walker, P A Svingen, et al.
Journal of Clinical Pharmacology|March 31, 2022
Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid TumorsEmily J Koubek, Andrew T Ralya, Thomas R Larson, et al.
Pageof 42

Showing results (341-350 of 416) with videos related to

Sort By:
Pageof 42
Neuro-Oncology|August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I studyKristin A Bradley, Ian F Pollack, Joel M Reid, et al.
BMC Research Notes|April 24, 2014
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I studyMin H Kang, Judith G Villablanca, Julia L Glade Bender, et al.
Science Advances|January 31, 2020
Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancerJimena G Dancy, Aniket S Wadajkar, Nina P Connolly, et al.
Medical and Pediatric Oncology|December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer GroupS A Feig, M M Ames, H N Sather, et al.
American Journal of Respiratory and Critical Care Medicine|September 5, 2009
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary diseaseChristine M Freeman, Fernando J Martinez, MeiLan K Han, et al.
Pediatric Blood & Cancer|April 5, 2013
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium studyTrent R Hummel, Lars Wagner, Charlotte Ahern, et al.
Nature|July 21, 2022
ADAR1 mutation causes ZBP1-dependent immunopathologyNicholas W Hubbard, Joshua M Ames, Megan Maurano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumorsMatthew P Goetz, Charles Erlichman, Anthony J Windebank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatinI I Budihardjo, D L Walker, P A Svingen, et al.
Journal of Clinical Pharmacology|March 31, 2022
Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid TumorsEmily J Koubek, Andrew T Ralya, Thomas R Larson, et al.
Pageof 42